Author

Kristen C. Vogt

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-5404-3442Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Almudena Chaves PereziD· 1 shared Ana Marie PereaiD· 1 shared Aveline A. FillioliD· 1 shared Charles M. RudiniD· 1 shared Clemens HinterleitneriD· 1 shared Daniel A. HelleriD· 1 shared Domhnall McHughiD· 1 shared Gabriel Dessotti BarrettoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Almudena Chaves PerezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologySciencePeer-reviewedSep 24, 2026

✦ In-depth digest

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

Clemens Hinterleitner, Valentin J.A. Barthet, Hailey V. Goldberg…·Scott W. Lowe

P-selectin-targeted fucoidan nanoparticles carrying Navitoclax or dBET6 deplete a senescent-like, lipid-associated macrophage subset, reverse mouse liver and lung fibrosis with less toxicity, and restore checkpoint therapy response in fibrotic tumors.

1 citationtop 4%

mousehuman

𝕏 PostBluesky